首页|期刊导航|老年心脏病学杂志（英文版）|Thirty-day outcomes of in-hospital multi-vessel versus culprit-only revascularization strategy for ST-segment elevation myocardial infarction with multivessel coronary disease
Thirty-day outcomes of in-hospital multi-vessel versus culprit-only revascularization strategy for ST-segment elevation myocardial infarction with multivessel coronary disease
Yu-Xi LI Bei-Ning WANG Fang-Fang FAN Yan ZHANG Jie JIANG Jian-Ping LI Ya-Ling HAN Yong Huo CCC investigators
老年心脏病学杂志（英文版）2023，Vol.20Issue(7)：485-494,10.
老年心脏病学杂志（英文版）2023，Vol.20Issue(7)：485-494,10.DOI:10.26599/1671-5411.2023.07.005
Thirty-day outcomes of in-hospital multi-vessel versus culprit-only revascularization strategy for ST-segment elevation myocardial infarction with multivessel coronary disease
Thirty-day outcomes of in-hospital multi-vessel versus culprit-only revascularization strategy for ST-segment elevation myocardial infarction with multivessel coronary disease
摘要
引用本文复制引用
Yu-Xi LI,Bei-Ning WANG,Fang-Fang FAN,Yan ZHANG,Jie JIANG,Jian-Ping LI,Ya-Ling HAN,Yong Huo,CCC investigators..Thirty-day outcomes of in-hospital multi-vessel versus culprit-only revascularization strategy for ST-segment elevation myocardial infarction with multivessel coronary disease[J].老年心脏病学杂志（英文版）,2023,20(7):485-494,10.基金项目
We thank all hospitals and staff participating in the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome(CCC-ACS)project.The CCC-ACS Project is a collaborative project of the Am-erican Heart Association and the Chinese Society of Cardiology.The American Heart Association recei-ved funding from Pfizer through an independent grant for learning and change and AstraZeneca as a qual-ity improvement initiative. （CCC-ACS）
